Date: September 19, 2024, 8:11 AM GMT
Executive summary: 23andMe is facing a major crisis with the resignation of its entire board of directors, excluding CEO Anne Wojcicki, due to disagreements over her plans to take the company private. The board members expressed dissatisfaction with the proposed buyout offer, deeming it insufficient and not in the best interests of shareholders. This follows a $30 million settlement reached by 23andMe to resolve a lawsuit concerning a data breach that exposed the personal information of nearly 6.9 million users. The company’s stock has tumbled by 7% following the board resignations, and it is currently facing a potential Nasdaq delisting.
Board Resignations and CEO Wojcicki’s Takeover Plan
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki
The entire board of directors of 23andMe, except for CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. This comes as Wojcicki is pursuing plans to take the company private. The board members expressed dissatisfaction with the proposed buyout offer, stating it was not adequate and did not represent the best interests of shareholders.
WSJ (13 hours ago)
23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by mass board resignation
Anne Wojcicki, CEO of 23andMe, expressed surprise and disappointment at the resignation of the company’s board of directors. The board members cited disagreements with Wojcicki’s strategic direction, particularly her plans to take the company private. The resignations come amid financial struggles for the company, with its stock plummeting by 7% following the news.
San Francisco Chronicle (15 hours ago)
23andMe’s independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
The seven independent directors of 23andMe have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private. The board members felt that the proposed buyout offer was not satisfactory and did not adequately represent the interests of shareholders. This mass resignation marks a significant blow to Wojcicki’s plans and raises questions about the future of the company.
New York Post (15 hours ago)
23andMe independent board directors resign en masse, rebuking Anne Wojcicki’s takeover plan
All seven independent directors of 23andMe have resigned, citing disagreements with CEO Anne Wojcicki’s plans to take the company private. The board members felt that Wojcicki’s proposed buyout offer was not satisfactory and did not represent the best interests of shareholders. This mass resignation is a significant setback for Wojcicki’s plans and could lead to uncertainty for the future of 23andMe.
Axios (12 hours ago)
23andMe Board resigns en masse amid CEO Anne Wojcicki’s plans to take DNA testing company private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. The board members felt that Wojcicki’s proposed buyout offer was not satisfactory and did not represent the best interests of shareholders. This mass resignation is a significant setback for Wojcicki’s plans and raises questions about the future of the company.
The Express Tribune (2 hours ago)
Data Breach and Lawsuit Settlement
23andMe agrees to $30 million settlement over data breach that targeted Jewish and Chinese users
23andMe has agreed to pay $30 million to settle a lawsuit concerning a data breach that exposed the personal information of nearly 6.9 million users. The lawsuit alleged that the breach targeted users of Jewish and Chinese descent, raising concerns about the potential misuse of sensitive genetic data. The settlement includes a payment to each affected user and will cover legal fees and other expenses.
VINnews (12 hours ago)
23andMe Reportedly Paying $30 Million to Settle Data Breach Suit
23andMe has agreed to a $30 million settlement to resolve a lawsuit stemming from a data breach that exposed the personal information of nearly 7 million users. The breach exposed sensitive data, including genetic information, and raised concerns about the company’s security practices. The settlement includes a payment to affected users and will cover legal fees and other expenses.
PYMNTS.com (3 days ago)
23andMe agrees to $30 million settlement after major data breach
Genetic testing company 23andMe has agreed to a $30 million settlement after a data breach exposed the personal information of approximately 6.9 million users. The lawsuit alleged that the breach targeted users of Jewish and Chinese descent, raising concerns about the potential misuse of sensitive genetic data. The settlement will cover legal fees and other expenses.
YouTube (1:40) (17 hours ago)
Company Performance and Future Outlook
23andMe Holding (ME) no longer in compliance with Nasdaq listing rules
23andMe Holding Co. has received a notification from Nasdaq that it is no longer in compliance with listing requirements. This follows the recent resignation of the company’s board of directors and the ongoing uncertainty surrounding CEO Anne Wojcicki’s plans to take the company private. The company has 180 days to regain compliance, which could involve a change in its business operations or a potential delisting.
StreetInsider (11 hours ago)
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan
Shares of 23andMe Holding Co. have tumbled by 7% following the resignation of the company’s independent board directors. The resignations come amidst disagreements with CEO Anne Wojcicki over her plans to take the company private. The board members expressed dissatisfaction with the proposed buyout offer, deeming it insufficient and not in the best interests of shareholders.
MarketWatch (20 hours ago)
23andMe faces potential Nasdaq delisting
23andMe Holding Co. is facing a potential Nasdaq delisting after receiving a notification of non-compliance from Nasdaq’s Listing Qualifications Department. The notification stems from the recent resignation of the company’s board of directors and the uncertainty surrounding CEO Anne Wojcicki’s plans to take the company private. The company has 180 days to regain compliance, which could involve a change in its business operations.
Investing.com India (5 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
All seven independent directors of 23andMe have resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the company’s strategic direction. The resignations come amid concerns about the company’s financial performance and the potential for a Nasdaq delisting. Wojcicki has expressed her commitment to taking the company private, but this move could face further challenges.
MSN (9 hours ago)
23andMe’s ‘$30M Settlement’ — Fair Agreement or Dangerous Precedent?
23andMe has agreed to a $30 million settlement to resolve a lawsuit stemming from a data breach that exposed the personal information of nearly 7 million users. The breach raised concerns about the company’s security practices and the potential for misuse of sensitive genetic data. This settlement raises questions about the adequacy of compensation for affected users and the broader implications for the genetic data industry.
Techopedia (20 hours ago)
Other 23andMe News
23andMe Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. This comes as the company faces financial struggles and a potential Nasdaq delisting. The resignations raise questions about the future of the company and its ability to overcome its current challenges.
Cheddar (14 hours ago)
‘DNA News: 23andMe Update’
Breaking DNA news about 23andMe and some advice for those who use their services.
YouTube (0:57) (14 hours ago)
‘The board of directors just resigned from 23andme #23andme …’
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. The resignations come amid financial struggles for the company and raise questions about the future of the company.
TikTok (1:07) (5 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Resignation
All seven independent directors of 23andMe have resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the company’s strategic direction. The resignations come amid concerns about the company’s financial performance and the potential for a Nasdaq delisting.
Dailymotion (0:36) (13 hours ago)
‘Breaches and Big Moves: 23andMe, MasterCard Acquisition …’
Drex covers critical updates in the cybersecurity landscape. 23andMe faces a $30 million payout to nearly 6.5 million users after a major data breach.
YouTube (3:35) (16 hours ago)
‘Tupperware, UAW-Stellantis, 23andme: 3 Stories In Focus’
All seven of the independent directors on 23andme’s (ME) board have resigned as the CEO Anne Wojcicki plans to take the company private. This news comes as the company faces financial struggles and a potential Nasdaq delisting.
Yahoo Finance (2:39) (17 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. The resignations come amid concerns about the company’s financial performance and the potential for a Nasdaq delisting.
MSN (24 hours ago)
23andMe Directors Quit Over CEO’s Lowball Takeover Offer
The seven independent directors of 23andMe have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private. The board members felt that the proposed buyout offer was not satisfactory and did not represent the best interests of shareholders.
Finimize (1 day ago)
23andMe Faces Potential Nasdaq Delisting
23andMe Holding Co. is facing a potential Nasdaq delisting after receiving a notification of non-compliance from Nasdaq’s Listing Qualifications Department. The notification stems from the recent resignation of the company’s board of directors and the uncertainty surrounding CEO Anne Wojcicki’s plans to take the company private.
MarketWatch (22 hours ago)
23andMe Holding (ME) no longer in compliance with Nasdaq listing rules
23andMe Holding Co. has received a notification from Nasdaq that it is no longer in compliance with listing requirements. This follows the recent resignation of the company’s board of directors and the ongoing uncertainty surrounding CEO Anne Wojcicki’s plans to take the company private.
TipRanks (20 hours ago)
23andMe Faces Potential Nasdaq Delisting
23andMe Holding Co. is facing a potential Nasdaq delisting after receiving a notification of non-compliance from Nasdaq’s Listing Qualifications Department. The notification stems from the recent resignation of the company’s board of directors and the uncertainty surrounding CEO Anne Wojcicki’s plans to take the company private.
Investing.com India (5 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction. This comes as the company faces financial struggles and a potential Nasdaq delisting.
Cheddar (14 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s CEO Anne Wojcicki ‘surprised and disappointed’ by mass board resignation
Anne Wojcicki, CEO of 23andMe, expressed surprise and disappointment at the resignation of the company’s board of directors.
San Francisco Chronicle (15 hours ago)
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki
The entire board of directors of 23andMe, except for CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
WSJ (13 hours ago)
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan
Shares of DNA-testing company 23andMe Holding Co. tumbled 7% early Wednesday, after the independent directors of the board announced their resignation as they clashed with CEO Anne Wojcicki over her plan to take the company private.
MarketWatch (20 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe’s CEO Anne Wojcicki ‘surprised and disappointed’ by mass board resignation
Anne Wojcicki, CEO of 23andMe, expressed surprise and disappointment at the resignation of the company’s board of directors.
San Francisco Chronicle (15 hours ago)
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki
The entire board of directors of 23andMe, except for CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
WSJ (13 hours ago)
23andMe Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
Cheddar (14 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
Cheddar (14 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
MSN (24 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
Cheddar (14 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
MSN (24 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
Cheddar (14 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
MSN (24 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
Cheddar (14 hours ago)
23andMe Board Resigns En Masse Amid Strategic Disagreements
The seven independent board members at DNA-testing company 23andMe Holding Co. have resigned in protest over plans to take the company private.
TipRanks (20 hours ago)
23andMe’s CEO Anne Wojcicki ‘Disappointed’ at Board Shakeup as All Seven Independent Directors Resign
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
MSN (24 hours ago)
23andMe Independent Board Members Resign, Call Out CEO Anne Wojcicki For Not ‘Actionable Proposal’ Despite Ample Time
Seven independent board members of 23andMe Holding Co. have resigned, citing disagreements with CEO Anne Wojcicki over her plan to take the company private.
Yahoo Finance (19 hours ago)
23andMe’s independent directors quit in clash with CEO over buyout plan
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki.
LabPulse.com (16 hours ago)
23andMe Board Quits Over Plans to Take DNA Testing Company Private
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
The Hill (12 hours ago)
23andMe’s Board Resigns Amid Financial Struggles
The entire board of directors of 23andMe, excluding CEO Anne Wojcicki, has resigned, citing disagreements over the company’s strategic direction.
[Cheddar](https://www.cheddar.com/media/23andme-board-re
